By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

LAB International 

445 Armand-Frappier Boulevard

Laval  Quebec  H7V 4B3  Canada
Phone: 450-973-2240 Fax: 450-973-2259


SEARCH JOBS


Industry
Biotechnology






Company News
LAB International (CC:LAB) Announces Name Change to Akela Pharma Inc. 7/12/2007 12:45:01 PM
LAB International (CC:LAB) Announces Positive Results from its Growth Hormone Releasing Hormone (GHRH) Phase II Trial 7/12/2007 9:33:27 AM
LAB International (CC:LAB) Licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica N.V. for Europe 6/21/2007 1:37:49 PM
LAB International (CC:LAB) to Hold its Annual General Meeting of Shareholders June 22, 2007 in Montreal 6/19/2007 12:50:57 PM
LAB International (CC:LAB) Reports Results for First Quarter of Fiscal 2007 5/15/2007 12:59:18 PM
LAB International (CC:LAB) to Hold First Quarter 2007 Conference Call and Webcast 5/10/2007 1:46:48 PM
LAB International (CC:LAB) Reports Results for Fourth Quarter and Fiscal 2006 3/26/2007 12:35:03 PM
LAB International (CC:LAB) to Hold Fourth Quarter and Fiscal 2006 Conference Call and Webcast 3/21/2007 11:06:22 AM
LAB International (CC:LAB) Announces Positive Results from the Open-Label Phase IIb Fentanyl TAIFUN(R) Trial - New Patent Application Submitted 3/5/2007 11:19:14 AM
LAB International (CC:LAB) Completes Patient Enrollment In Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial 2/8/2007 9:57:11 AM
1234567
//-->